Central Bank of Savings Banks Finland Plc
Central Bank of Savings Banks Finland Plc's IFRS financial statements and Board of Directors' report for 2020 have been published.
Stock Exchange Release
16th of February 2021 at 8 am (CET +1)
The IFRS financial statements and Board of Directors' report for 2020 have been published. The materials are attached to this release and available in English and Finnish at www.saastopankki.fi.
Further information:
Kai Brander, Managing Director
Central Bank of Savings Banks Finland Plc
kai.brander@saastopankki.fi
+358 50 384 8220
Central Bank of Savings Banks Finland Plc is part of the Savings Banks Amalgamation and Savings Banks Group and operates as Group's central credit institution. Central Bank of Savings Banks' role is to ensure liquidity and wholesale funding of the Savings Banks Group via operating in the money and capital markets, issue payment cards, and provide payment transfer and account operator services.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Digital Check Corp.14.10.2025 06:01:00 CEST | Press release
Digital Check Introduces Next-Generation TellerScan® TS250 UV Ultraviolet Scanner
Mavenir Systems, Inc.14.10.2025 06:00:00 CEST | Press release
e& and Mavenir unveil AI-powered voice service security and anti-fraud collaboration
Biogen Inc.14.10.2025 01:30:00 CEST | Press release
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”
Bombardier Inc.13.10.2025 22:02:56 CEST | Press release
Bombardier Global 8000, The World’s Fastest Business Jet, Gets Even Faster with a New Top Speed of Mach 0.95
Zymeworks Inc.13.10.2025 22:00:00 CEST | Press release
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom